15 January 2025
Health Care Law Today
AI Drug Development: FDA Releases Draft Guidance
On January 6, 2025, the U.S. Food and Drug Administration released draft guidance titled Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products explaining the types of information that the agency may seek during drug evaluation.